Catalyst Wire Dossier Catalyst Wire Dossier

FMX114

· Vyne Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FMX114, covering 2022-08-31 to 2022-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis [Phase 1, Phase 2]

See pricing